HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nestor Avgoustidis Selected Research

Eosinophilic Fasciitis

10/2021Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review.
1/2020Eosinophilic Fasciitis in a Patient With Crohn's Disease Treated With Infliximab. A Rare Coexistence or a Drug-related Manifestation?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nestor Avgoustidis Research Topics

Disease

3Rheumatoid Arthritis
12/2023 - 01/2022
2Rheumatic Diseases (Rheumatism)
11/2023 - 08/2018
2Eosinophilic Fasciitis
10/2021 - 01/2020
1Osteoarthritis
01/2024
1Pain (Aches)
01/2024
1Fibromyalgia (Fibrositis)
01/2024
1Metabolic Diseases (Metabolic Disease)
01/2024
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2023
1Obesity
10/2023
1Spondylarthritis (Spinal Arthritis)
10/2023
1Axial Spondyloarthritis
10/2023
1Autoimmune Diseases (Autoimmune Disease)
10/2021
1Uveitis
09/2021
1Crohn Disease (Crohn's Disease)
01/2020
1Systemic Scleroderma (Systemic Sclerosis)
03/2019
1Arthritis (Polyarthritis)
09/2018
1Pericarditis
08/2018
1Infections
01/2018

Drug/Important Bio-Agent (IBA)

2Rituximab (Mabthera)FDA Link
01/2022 - 10/2021
11- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA
01/2024
1Antirheumatic Agents (DMARD)IBA
01/2024
1Monoclonal AntibodiesIBA
12/2023
1Abatacept (Orencia)FDA Link
12/2023
1Tumor Necrosis Factor InhibitorsIBA
10/2023
1Etanercept (Enbrel)FDA Link
10/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2021
1Infliximab (Remicade)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
03/2019
1ametantrone (HAQ)IBA
09/2018
1canakinumabFDA Link
08/2018

Therapy/Procedure

3Therapeutics
01/2024 - 10/2023
1Biological Therapy
01/2018